Apelian David 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Mar 26, 2019
Insider Transaction Report
Form 4
Apelian David
Director
Transactions
- Award
Stock Option ( Right to Buy)
2019-03-21+110,500→ 110,500 totalExercise: $14.31Exp: 2029-03-20→ Common Stock (110,500 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 48 months measured from March 21, 2019 subject to Reporting Person's continuous service status as of each such date.